Last reviewed · How we verify

NCT05756998

New Method of IUD Insertion During Cesarian Section

Status unknown NA Last updated 7 March 2023
What this trial tests

NA trial testing Copper T380 IUD ( Paragard 380 A ,CooperSurgical, Inc. © 2022) (classic technique) in Postpartum Contraception in 156 participants. Status unknown.

Timeline
2 February 2022
Primary endpoint
28 February 2023
15 March 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposehealth services research
Enrollment156
Start date2 February 2022
Primary completion28 February 2023
Estimated completion15 March 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, female only, with Postpartum Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In women undergoing elective CS, half of them will have Intra-caesarian copper T 380 IUD insertion using the standard method and the remaining half will undergo copper T 380 IUD insertion during CS using a new technique in order to detect which technique is more effective in having more accurate IUD position with visible threads.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing